Selected research
Industry Research
Isoxazoline Drugs Industry Research Report 2026
Market perspective
The global Isoxazoline Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Isoxazoline Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Isoxazoline Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Isoxazoline Drugs include Zoetis Inc, Nissan Chemical Corporation, Merck Animal Health Inc., Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Isoxazoline Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Isoxazoline Drugs Market by Company
Zoetis Inc
Nissan Chemical Corporation
Merck Animal Health Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Isoxazoline Drugs Segment by Type
Sarolaner
Lotilaner
Fluralaner
Afoxolaner
Others
Isoxazoline Drugs Segment by Application
Dog
Cat
Others
Isoxazoline Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoxazoline Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isoxazoline Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoxazoline Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Isoxazoline Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Isoxazoline Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sarolaner
- Lotilaner
- Fluralaner
- Afoxolaner
- Others
Applications
- Dog
- Cat
- Others
Companies covered
- Zoetis Inc
- Nissan Chemical Corporation
- Merck Animal Health Inc.
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Isoxazoline Drugs Market Size (2021-2032)
- 2.2.2 Global Isoxazoline Drugs Sales (2021-2032)
- 2.2.3 Global Isoxazoline Drugs Market Average Price (2021-2032)
- 2.3 Isoxazoline Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sarolaner
- 2.3.3 Lotilaner
- 2.3.4 Fluralaner
- 2.3.5 Afoxolaner
- 2.3.6 Others
- 2.4 Isoxazoline Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dog
- 2.4.3 Cat
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Isoxazoline Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Isoxazoline Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Isoxazoline Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Isoxazoline Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Isoxazoline Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Isoxazoline Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Isoxazoline Drugs, Product Type & Application
- 3.8 Global Manufacturers of Isoxazoline Drugs, Established Date
- 3.9 Global Isoxazoline Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis Inc
- 4.1.1 Zoetis Inc Company Information
- 4.1.2 Zoetis Inc Business Overview
- 4.1.3 Zoetis Inc Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Inc Isoxazoline Drugs Product Portfolio
- 4.1.5 Zoetis Inc Recent Developments
- 4.2 Nissan Chemical Corporation
- 4.2.1 Nissan Chemical Corporation Company Information
- 4.2.2 Nissan Chemical Corporation Business Overview
- 4.2.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio
- 4.2.5 Nissan Chemical Corporation Recent Developments
- 4.3 Merck Animal Health Inc.
- 4.3.1 Merck Animal Health Inc. Company Information
- 4.3.2 Merck Animal Health Inc. Business Overview
- 4.3.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio
- 4.3.5 Merck Animal Health Inc. Recent Developments
- 4.4 Elanco Animal Health Incorporated
- 4.4.1 Elanco Animal Health Incorporated Company Information
- 4.4.2 Elanco Animal Health Incorporated Business Overview
- 4.4.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio
- 4.4.5 Elanco Animal Health Incorporated Recent Developments
- 4.5 Boehringer Ingelheim International GmbH
- 4.5.1 Boehringer Ingelheim International GmbH Company Information
- 4.5.2 Boehringer Ingelheim International GmbH Business Overview
- 4.5.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio
- 4.5.5 Boehringer Ingelheim International GmbH Recent Developments
5 Global Isoxazoline Drugs Market Scenario by Region
- 5.1 Global Isoxazoline Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Isoxazoline Drugs Sales by Region: 2021-2032
- 5.2.1 Global Isoxazoline Drugs Sales by Region: 2021-2026
- 5.2.2 Global Isoxazoline Drugs Sales by Region: 2027-2032
- 5.3 Global Isoxazoline Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Isoxazoline Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Isoxazoline Drugs Revenue by Region: 2027-2032
- 5.4 North America Isoxazoline Drugs Market Facts & Figures by Country
- 5.4.1 North America Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Isoxazoline Drugs Sales by Country (2021-2032)
- 5.4.3 North America Isoxazoline Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Isoxazoline Drugs Market Facts & Figures by Country
- 5.5.1 Europe Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Isoxazoline Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Isoxazoline Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Isoxazoline Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Isoxazoline Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Isoxazoline Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Isoxazoline Drugs Market Facts & Figures by Country
- 5.7.1 South America Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Isoxazoline Drugs Sales by Country (2021-2032)
- 5.7.3 South America Isoxazoline Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Isoxazoline Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Isoxazoline Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Isoxazoline Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Isoxazoline Drugs Sales by Type (2021-2032)
- 6.1.1 Global Isoxazoline Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Isoxazoline Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Isoxazoline Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Isoxazoline Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Isoxazoline Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Isoxazoline Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Isoxazoline Drugs Sales by Application (2021-2032)
- 7.1.1 Global Isoxazoline Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Isoxazoline Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Isoxazoline Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Isoxazoline Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Isoxazoline Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Isoxazoline Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Isoxazoline Drugs Value Chain Analysis
- 8.1.1 Isoxazoline Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Isoxazoline Drugs Production Mode & Process
- 8.2 Isoxazoline Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Isoxazoline Drugs Distributors
- 8.2.3 Isoxazoline Drugs Customers
9 Global Isoxazoline Drugs Analyzing Market Dynamics
- 9.1 Isoxazoline Drugs Industry Trends
- 9.2 Isoxazoline Drugs Industry Drivers
- 9.3 Isoxazoline Drugs Industry Opportunities and Challenges
- 9.4 Isoxazoline Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst